Author

Muhammad Arif Khan

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Efficacy and safety of guselkumab for inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials.

Crohn's disease and ulcerative colitis are chronic inflammatory bowel diseases (IBDs) driven by the interleukin-23/Th17 pathway. Guselkumab, a selective interleukin-23p19 monoclonal antibody, has shown promise in phase II/III trials. This systematic review and meta-analysis aimed to synthesize its efficacy and safety v...

Z. Shahid, M. Azam, Ahila Ali et al. · European Journal of Gastroen... · 0 citations

Review Open access Sep 2026

Doravirine and islatravir for HIV-1 treatment: A systematic review and meta-analysis with GRADE assessment

Background Two-drug antiretroviral regimens are increasingly explored to simplify HIV-1 treatment while maintaining durable viral suppression. Doravirine combined with Islatravir (DOR/ISL) represents a novel non-integrase strand transfer inhibitor (non-INSTI) regimen. However, comprehensive synthesized evidence remains...

M. Azam, M. Azam, Muhammad Arif Khan et al. · Therapeutic Advances in Infe... · 0 citations